Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
3,4 These metabolic comorbidities, such as obesity, insulin resistance, and cardiovascular disease, exacerbate disease severity and complicate management
:max_bytes(150000):strip_icc()/VWH-GettyImages-1807240345-087c9b9e2e9b4a689e1c8ab33363762b.jpg)
Readers are encouraged to consult the primary publication (Rosenstock et al., The Lancet, 2023) and the ClinicalTrials.gov record for full participant numbers, confidence intervals, and protocol details
Similarly, other emerging evidence suggests that discontinuation of GLP-1 treatment, even for limited periods, could increase the risk of heart disease in adults with Type 2 diabetes
The compound may also reduce fasting blood sugar, according to 2023 research in Frontiers in Nutrition
US$ 21.33
US$ 28.26
US$ 20.63
